Home
About IBT
IBT History
Management
Board of Directors
Advisory Board
Sustainability Policy
Pipeline
IBP-9414
IBP-1016
IBP-1118
IBP-1122
Expanded Access Policy for Investigational Drugs
Healthcare Professionals
Investors & Media
Shares
Share Issue
Ownership Structure
Corporate Governance
Calendar
Financial Reports
Press Releases
Investors & Media Contact
Contact Us
Career
En
Sv
Home
About IBT
IBT History
Management
Board of Directors
Advisory Board
Sustainability Policy
Pipeline
IBP-9414
IBP-1016
IBP-1118
IBP-1122
Expanded Access Policy for Investigational Drugs
Healthcare Professionals
Investors & Media
Shares
Share Issue
Ownership Structure
Corporate Governance
Calendar
Financial Reports
Press Releases
Investors & Media Contact
Contact Us
Career
Press releases
Prospectus relating to Infant Bacterial Therapeutics’ rights issue published
January 10, 2018
To access the press release, please read the following disclaimer
here
.
Latest press releases
2026-09-18 10:40
NOMINATION COMMITTEE FOR INFANT BACTERIAL THERAPEUTICS AB (PUBL) FOR THE ANNUAL GENERAL MEETING 2027
Regulatory
2026-08-26 07:30
Infant Bacterial Therapeutics AB (publ) Interim report January 1 – June 30, 2026
Regulatory
2026-07-07 12:05
Infant Bacterial Therapeutics CFO Leaves the Company
Regulatory
2026-05-07 17:15
Annual General Meeting of Infant Bacterial Therapeutics
Regulatory
2026-05-06 14:00
Infant Bacterial Therapeutics AB (publ) Interim report January 1 – March 31, 2026
Regulatory